文献速递心律失常

心房颤动负担与心脏植入电子设备患者死亡率的关联

Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.
PubMed 文献 · Circulation · 2024-06-28

调整年龄、地区、保险类型、Charlson共病指数和植入年份后,AF患者全因死亡率显著高于无AF患者(HR 1.29,95%CI 1.20-1.39,P<0.001),非阵发性AF死亡风险最高。

要点

  • 设备识别AF患者调整后全因死亡风险较无AF者高29%。
  • 非阵发性AF死亡风险高于阵发性AF,持续性和永久性AF均显著。
  • 设备连续监测的AF负担可用于危险分层。

核心结论

  • 调整潜在混杂因素后,心脏植入电子设备患者中设备识别的AF与更高全因死亡率相关。
  • 在AF患者中,非阵发性AF与最高死亡风险相关。

研究设计与样本

  • 回顾性队列研究,链接Optum Clinformatics美国索赔数据库(2015-2020)与Medtronic CareLink数据库。
  • AF负担在植入后前6个月(基线期)评估,后续死亡率从索赔数据获取。
  • 采用多变量调整年龄、地理区域、保险类型、Charlson共病指数和植入年份。

主要发现

  • 7798例(36.5%)存在设备识别的AF。
  • 平均随访22.4±12.9个月(中位20.1个月,范围12.8-29.7个月),总死亡率为13.5%。
  • AF患者调整后全因死亡率高于无AF患者(HR 1.29,95%CI 1.20-1.39,P<0.001)。
  • 持续性AF vs 阵发性AF:HR 1.36(95%CI 1.18-1.58,P<0.001)。
  • 永久性AF vs 阵发性AF:HR 1.23(95%CI 1.14-1.34,P<0.001)。

临床怎么用

  • 对于植入心脏电子设备的患者,应关注设备记录的AF负担,尤其是非阵发性AF,以识别高危人群。
  • 设备连续监测的AF信息可用于死亡风险分层,辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current estimates of atrial fibrillation (AF)-associated mortality rely on claims- or clinical-derived diagnoses of AF, limit AF to a binary entity, or are confounded by comorbidities. The objective of the present study is to assess the association between device-recognized AF and mortality among patients with cardiac implantable electronic devices capable of sensitive and continuous atrial arrhythmia detection. Secondary outcomes include relative mortality among cohorts with no AF, paroxysmal AF, persistent AF, and permanent AF. METHODS: Using the deidentified Optum Clinformatics US claims database (2015 to 2020) linked to the Medtronic CareLink database, we identified individuals with a cardiac implantable electronic device who transmitted data ≥6 months after implantation. AF burden was assessed during the first 6 months after implantation (baseline period). Subsequent mortality, assessed from claims data, was compared between patients with and without AF, with adjustment for age, geographic region, insurance type, Charlson Comorbidity Index, and implantation year. RESULTS: Of 21 391 patients (age, 72.9±10.9 years; 56.3% male) analyzed, 7798 (36.5%) had device-recognized AF. During a mean of 22.4±12.9 months (median, 20.1 [12.8-29.7] months) of follow-up, the overall incidence of mortality was 13.5%. Patients with AF had higher adjusted all-cause mortality than patients without AF (hazard ratio, 1.29 [95% CI, 1.20-1.39]; P<0.001). Among those with AF, patients with nonparoxysmal AF had the greatest risk of mortality (persistent AF versus paroxysmal AF: hazard ratio, 1.36 [95% CI, 1.18-1.58]; P<.001; permanent AF versus paroxysmal AF: hazard ratio, 1.23 [95% CI, 1.14-1.34]; P<.001). CONCLUSIONS: After adjustment for potential confounding factors, the presence of AF was associated with higher mortality in our cohort of patients with cardiac implantable electronic devices. Among those with AF, nonparoxysmal AF was associated with the greatest risk of mortality.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Peigh G, Zhou J, Rosemas SC, et al. Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices. Circulation. 2024. PMID: 38940005. doi:10.1161/CIRCULATIONAHA.124.069757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。